Skip to main content
Corbus Pharmaceuticals Holdings, Inc. (LON: 0SZI)
London flag London · Delayed Price · Currency is GBP · Price in USD
10.82
-0.59 (-5.21%)
Jan 23, 2025, 6:38 PM BST

Corbus Pharmaceuticals Holdings Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
112.24M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021881.71K-3.06M-77.61%
Dec 31, 20203.94M-32.21M-89.11%
Dec 31, 201936.14M31.32M649.51%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 38.20B
GSK plc 31.31B
Haleon 11.24B
Smith & Nephew 4.46B
ConvaTec Group 1.74B
Hikma Pharmaceuticals 2.39B
HUTCHMED (China) 483.31M
Oxford Nanopore Technologies 167.75M
Revenue Rankings

Corbus Pharmaceuticals Holdings News

More News